|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



*
Department of Rheumatology, University Hospital, Zürich, Switzerland;
M. E. Müller Institute for Biomechanics, University of Bern, Bern, Switzerland; and
Ferguson Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
During inflammatory joint diseases, chondrocytes are exposed to cytokines such as IL-1 that induce the synthesis of nitric oxide (NO). Chondrocytes from different zones of the articular cartilage are known to have different metabolic properties. In the present study, we have demonstrated that chondrocytes recovered from the superficial zone of normal, human, articular cartilage synthesize approximately 2 to 3 times as much NO in response to IL-1 as chondrocytes recovered from the deep zone of the same cartilage. Production of NO by normal cartilage in response to IL-1 was also found to decrease with age. Addition of the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMA, 1 mM) blocked NO production by cells of both zones. L-NMA completely reversed the suppression of proteoglycan synthesis imposed by IL-1 in deep chondrocytes, but produced only partial reversal in superficial cells. As noted previously, IL-1 failed to elicit a strong catabolic response in cultures of human cartilage. In the presence of L-NMA, however, IL-1 reduced the metabolic t1/2 of proteoglycans by approximately 50% in both the superficial and deep zones. This suggests that NO has, directly or indirectly, an anticatabolic effect in human cartilage. These data confirm the metabolic heterogeneity of human chondrocytes, and suggest that NO may be involved to different degrees as an endogenous modulator of the turnover of the cartilaginous matrix in different zones of articular cartilage.
This article has been cited by other articles:
![]() |
N. Taniguchi, B. Carames, Y. Kawakami, B. A. Amendt, S. Komiya, and M. Lotz Chromatin protein HMGB2 regulates articular cartilage surface maintenance via {beta}-catenin pathway PNAS, September 29, 2009; 106(39): 16817 - 16822. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chiossi, G. Verocchi, P. Venturini, and F. Facchinetti Changes in Cervical Nitric Oxide Concentration Correlate With Bishop Score and Cervical Length Modifications in Prostaglandin E2-Mediated Induction of Labor Reproductive Sciences, April 1, 2006; 13(3): 203 - 208. [Abstract] [PDF] |
||||
![]() |
N. J. Goodstone and T. E. Hardingham Tumour necrosis factor {alpha} stimulates nitric oxide production more potently than interleukin-1{beta} in porcine articular chondrocytes Rheumatology, August 1, 2002; 41(8): 883 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Teixeira, K. Mansfield, C. Hertkorn, H. Ischiropoulos, and I. M. Shapiro Phosphate-induced chondrocyte apoptosis is linked to nitric oxide generation Am J Physiol Cell Physiol, September 1, 2001; 281(3): C833 - C839. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Shirazi, I Yaron, Y Wollman, M Blum, T Chernihovsky, R Judovich, A Iaina, and M Yaron Down regulation of interleukin 1{beta} production in human osteoarthritic synovial tissue and cartilage cultures by aminoguanidine Ann Rheum Dis, April 1, 2001; 60(4): 391 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Ledingham, A. J. Thomson, A. Young, L. M. Macara, I. A. Greer, and J. E. Norman Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition Mol. Hum. Reprod., November 1, 2000; 6(11): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gassner, M. J. Buckley, H. Georgescu, R. Studer, M. Stefanovich-Racic, N. P. Piesco, C. H. Evans, and S. Agarwal Cyclic Tensile Stress Exerts Antiinflammatory Actions on Chondrocytes by Inhibiting Inducible Nitric Oxide Synthase J. Immunol., August 15, 1999; 163(4): 2187 - 2192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |